中国实用外科杂志

中国实用外科杂志

• 述评 • 上一篇    下一篇

甲状腺癌病人生存现状分析

田    文，郗洪庆   

  1. 中国人民解放军总医院普通外科，北京 100853
  • 出版日期:2016-05-01 发布日期:2016-04-28

  • Online:2016-05-01 Published:2016-04-28

摘要：

甲状腺癌是目前发病率增长最快的实体恶性肿瘤。2012年，我国癌症登记中心的年报显示，城市人群中甲状腺癌位居癌症患病的第4位。美国2003-2009年调查数据显示，甲状腺癌5年存活率为98.2%；2014年，欧洲发布的统计数据显示，甲状腺癌5年存活率为86.5%。尽管我国部分三甲医院调查数据显示，甲状腺癌5年存活率>90.0%，但2014年国家癌症中心发布的最新数据中甲状腺癌5年存活率仅为67.5%。该数据覆盖基层医院、二级和三级医院，代表全国平均诊疗水平。从流行病学特点、整体预后现状进行综合分析认为，对分化型甲状腺癌（包括甲状腺微小癌）须提倡早期诊断和积极规范的以外科为主的综合治疗，从而提高我国甲状腺癌病人存活率。

关键词: 甲状腺癌, 存活率, 预后, 生存分析

Abstract:

Analysis of the survival status of patients with thyroid carcinoma        TIAN Wen，XI Hong-qing. Department of General Surgery，Chinese People’s Liberation Army General Hospital，Beijing 100853，China
Corresponding author：TIAN Wen，E-mail：tianwen301_cta01@163.com
Abstract    In recent years，the incidence of thyroid cancer has been increasing the fastest among all solid malignant tumors worldwide. In 2012，Chinese cancer registries annual report showed that it was the fourth common malignancy in urban area of China. In America，the data between 2003 and 2009 suggested that the five-year survival rate of thyroid cancer was up to 98.2% and the newest data published in 2014 was 86.5% in European countries. Although the five-year survival rate of thyroid cancer is more than 90% in some Chinese 3A grade hospitals，it is only 67.5%（2003-2005） according to the newest data published by National Cancer Institute in 2014. Moreover，the data of such a low rate was extracted from 3A grade hospitals, 2A grade hospitals and primary hospitals, representing the domestic situation. The epidemiological features and current prognosis of thyroid cancer were analyzed. For differentiated thyroid carcinoma including thyroid microcarcinoma，the early diagnosis and standardized treatment should be advocated to improve the survival rate of thyroid cancer in China.

Key words: thyroid cancer, survival rate, prognosis, survival analysis